American Capital Advisory’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$601 Sell
21
-8
-28% -$254 ﹤0.01% 915
2026
Q1
$913 Buy
29
+21
+263% +$662 ﹤0.01% 715
2025
Q4
$236 Hold
8
﹤0.01% 902
2025
Q3
$202 Buy
+8
New +$195 ﹤0.01% 874

Other funds holding RTO

American Capital Advisory's RTO Position: Q2 2026 in Review

American Capital Advisory reduced its Rentokil (RTO) stake by 28% in Q2 2026, selling an estimated $254 and leaving 21 shares worth $601. The position accounts for ﹤0.01% of the portfolio, ranked #915.

American Capital Advisory first reported a position in RTO in Q3 2025 and has held it in 4 quarters since. The position peaked at $913 in Q1 2026. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • American Capital Advisory held 21 shares of Rentokil worth $601 as of Q2 2026.
  • American Capital Advisory sold 8 Rentokil shares in Q2 2026, an estimated $254.
  • Rentokil made up ﹤0.01% of American Capital Advisory's portfolio in Q2 2026, its #915 holding.
  • American Capital Advisory first reported a position in Rentokil in Q3 2025 and has held it in 4 quarters since.
  • American Capital Advisory's Rentokil position peaked at $913 in Q1 2026.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.